Histologic characterization of the immune infiltrate in isocitrate dehydrogenase wild-type and mutant World Health Organization Grade II and III gliomas
Aim: This study aims to describe the immune infiltrations in low-grade glioma (LGG) with respect to their histological classification, isocitrate dehydrogenase 1 and 2 (IDH1/2) mutation status and survival. Materials and Methods: The IDH1/2 status (mutant or wild-type) of 66 World Health Organizatio...
Main Authors: | Josine A. E. M. Jansen, Wim G. M. Spliet, Wendy de Leng, Pierre Alain Robe |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Glioma |
Subjects: | |
Online Access: | http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=6;spage=196;epage=200;aulast=Jansen |
Similar Items
-
Biochemical Characterization and Genetic Modeling of Glioma-Associated Mutations in Isocitrate Dehydrogenases.
by: Lopez, Giselle Yvette
Published: (2014) -
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
by: Danielle Golub, et al.
Published: (2019-05-01) -
Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development
by: Juan Huang, et al.
Published: (2019-06-01) -
Screening of Methylation Signature and Gene Functions Associated With the Subtypes of Isocitrate Dehydrogenase-Mutation Gliomas
by: XiaoYong Pan, et al.
Published: (2019-11-01) -
Role of natural killer cells in isocitrate dehydrogenase 1/2 mutant glioma pathogenesis and emerging therapies
by: Xiaoran Zhang, et al.
Published: (2019-01-01)